Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease
Inflammatory Bowel Diseases2006Vol. 13(1), pp. 57–64
Citations Over TimeTop 10% of 2006 papers
Gabriele Stocco, Stefano Martelossi, A. Barabino, Giuliana Decorti, Fiora Bartoli, Marcella Montico, A Gotti, Alessandro Ventura
Abstract
Patients with IBD with a wildtype GST-M1 genotype present increased probability of developing adverse effects and increased incidence of lymphopenia during azathioprine treatment.
Related Papers
- Importance of thiopurine S-Methyltransferase gene polymorphisms for prediction of azathioprine toxicity.(2009)
- → Fatal Myelotoxicity After Azathioprine Treatment(2008)20 cited
- → METABOLISM OF AZATHIOPRINE(1996)4 cited
- → Role of Monitoring Thiopurine Methyltransferase (TPMT) Activity in the Individualized Therapy with Azathioprine or 6-Mercaptopurine(2008)1 cited
- Analysis of Thiopurine S-methyltransferase Genotype and Azathioprine Safety in Patients with Inflammatory Bowel Disease(2012)